Successful treatment of secondary poor graft function post allogeneic hematopoietic stem cell transplantation with eltrombopag

[1]  M. Michaelis,et al.  The Thrombopoietin Receptor Agonist Eltrombopag Inhibits Human Cytomegalovirus Replication Via Iron Chelation , 2019, bioRxiv.

[2]  Xiao-jun Huang,et al.  Granulocyte Colony-Stimulating Factor-Primed Unmanipulated Haploidentical Blood and Marrow Transplantation , 2019, Front. Immunol..

[3]  Rajat Kumar,et al.  Eltrombopag: Role in Cytopenias Following Hematopoietic Stem Cell Transplantation , 2019, Indian Journal of Hematology and Blood Transfusion.

[4]  Heather D. Huntsman,et al.  Eltrombopag maintains human hematopoietic stem and progenitor cells under inflammatory conditions mediated by IFN-γ. , 2019, Blood.

[5]  J. Bussel,et al.  Safety and efficacy of long-term treatment of chronic/persistent ITP with eltrombopag: final results of the EXTEND study. , 2017, Blood.

[6]  F. Gao,et al.  Fresh or Cryopreserved CD34+-Selected Mobilized Peripheral Blood Stem and Progenitor Cells for the Treatment of Poor Graft Function after Allogeneic Hematopoietic Cell Transplantation. , 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[7]  B. Dumitriu,et al.  Eltrombopag Added to Standard Immunosuppression for Aplastic Anemia , 2017, The New England journal of medicine.

[8]  S. Fuji,et al.  Eltrombopag for Treatment of Thrombocytopenia after Allogeneic Hematopoietic Cell Transplantation. , 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[9]  Xiuli Wu,et al.  Improvement in Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation upon Administration of Mesenchymal Stem Cells from Third-Party Donors: A Pilot Prospective Study , 2012, Cell transplantation.

[10]  Yan-rong Liu,et al.  Association of an impaired bone marrow microenvironment with secondary poor graft function after allogeneic hematopoietic stem cell transplantation. , 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[11]  L. Adès,et al.  Granulocyte colony-stimulating factor for poor graft function after allogeneic stem cell transplantation: 3 days of G-CSF identifies long-term responders , 2005, Bone Marrow Transplantation.

[12]  J. Lee,et al.  Failure of trilineage blood cell reconstitution after initial neutrophil engraftment in patients undergoing allogeneic hematopoietic cell transplantation – frequency and outcomes , 2004, Bone Marrow Transplantation.

[13]  D. Blaise,et al.  Second early allogeneic stem cell transplantations for graft failure in acute leukaemia, chronic myeloid leukaemia and aplastic anaemia. French Society of Bone Marrow Transplantation. , 2000 .

[14]  D. Blaise,et al.  Second early allogeneic stem cell transplantations for graft failure in acute leukaemia, chronic myeloid leukaemia and aplastic anaemia , 2000, British journal of haematology.

[15]  C. Anasetti,et al.  Allogeneic hematopoietic stem‐cell engraftment and graft failure , 1999, Pediatric transplantation.